Simone Dokter
- Algorithms
- Billing code
- Biomarker
- Cancer of Unknown Primary
- DNA
- End of Treatment
- Hartwig Medical Database
- Hartwig Medical Foundation
- IT
- Lab process
- Learning healthcare system
- Molecular diagnostics
- OncoAct
- Participating hospitals
- Patients' stories
- Personalized treatment
- Quality
- Rare cancers
- Research
- Scientific publications
- Uncategorized
- Whole genome sequencing
- Working in the cloud
Simone Dokter
The complete DNA test is an additional tool to help us discover the origin of the cancer in patients with …
Job van Riet
Hartwig’s unique data set has enriched our understanding of metastatic cancer.
Vincent Smit
WGS is a helpful addition to our toolbox, alongside the classic HE, IHC and the (broad) NGS panels and should …
Emile Voest
Just one WGS test is enough to reveal everything you need to know to provide a patient with metastatic cancer …
Gerrit Meijer
Cancer is caused by DNA mutations. There are an increasing number of drugs available that act on specific errors in …
Andrea van Puffelen
The knowledge we gather with WGS can bring us a step closer to our goal to find an effective and …
Warnyta Minnaard
If the practitioner doesn’t know where the primary tumor is located, they cannot offer a targeted treatment plan, and nor …
Laurens Beerepoot
In our profession, we need to know everything about the patient, but we also want to know as much as …
René Medema
We have been using the complete DNA test for the past two years in the routine care of patients with …
Miriam Koopman
A complete genetic analysis should be part of the standard diagnostics for every patient with cancer who is eligible for …
Louisa Hoes
Cancers will increasingly meet the definition of ‘rare’ in terms of the molecular profiles that make each tumor unique. The …
Ernst Kuipers
It is essential to record and share data to ensure good care.
Personalised selection of experimental treatment in patients with advanced solid cancer is feasible using whole-genome sequencing.
